We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.75 | 3.70 | 3.80 | 3.75 | 3.75 | 3.75 | 27 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.86 | 2.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/4/2024 15:04 | Royalties have the potential to bring in much higher revenues, good choice by the company, I expect many more contracts to start feeding through. | deltalo | |
15/4/2024 11:36 | What is the upfront value??? | inaminute | |
15/4/2024 10:56 | Great news this morning I have had another top up more to follow | bobaxe1 | |
15/4/2024 07:29 | It’s a new technology and second strand of their Optimal programme alongside the AI OptiPhageTM, a phage display based version of the same DNA library. OptiPhageTM uses the same DNA sequences as OptiMAL® but packages them into a more commonly used Phage display format. Only smaller antibody fragments can be screened in this way, compared to whole antibodies via OptiMAL®, but it can be run at a lower price point for the customer. The Directors believe that the provision of OptiPhageTM provides the Company with an ability to protect the premium pricing of the OptiMAL® programme whilst meeting budgetary constraints of its customers. It may also be the platform of choice for those wanting antibody fragments as their end product; | gtc1508 | |
15/4/2024 07:23 | Nice contract - not much upfront in terms of value, but royalties seems a good model | paulisi | |
15/4/2024 07:20 | Excellent news this is the start of the recovery | bigjock36 | |
10/4/2024 11:04 | Interesting pickup today | ksddw2 | |
04/4/2024 21:30 | Good chart here !//https://x.com/dar | bobaxe1 | |
02/4/2024 15:00 | Just read your last 10 posts, another bot for the filter bin... | troutisout | |
02/4/2024 14:56 | Yep fab considering delisting needs shareholder vote to agree | beatme1 | |
02/4/2024 10:31 | They do not have billions of shares | bobaxe1 | |
02/4/2024 09:51 | Bought APH , Alliance Pharma plc , growing profitable health care company | blackhorse23 | |
02/4/2024 08:38 | Hearing fab want to delist following other pharma stocks | beatme1 | |
22/3/2024 18:56 | I agree I bought at 3.73Fully funded and ready for a re-rate | bigjock36 | |
22/3/2024 14:48 | No brainier down here | bobaxe1 | |
21/3/2024 13:36 | According to the financials we have 10x cash to Mcap surly that is not so ? | bobaxe1 | |
15/3/2024 16:03 | Just topped up shows red good price not complaining | bobaxe1 | |
14/3/2024 13:22 | https://x.com/fsnant | bobaxe1 | |
07/3/2024 12:19 | Looking good, I think they want to take it higher | soultrading | |
07/3/2024 08:37 | Picking up here | bobaxe1 | |
05/3/2024 15:36 | Decent 901k buy there ?? | bigjock36 | |
03/3/2024 21:16 | Some decent news after placing and 7 should not be an issue | bigjock36 | |
01/3/2024 11:19 | Nice to see a bit of action back, another assault on 7s please, GLA | lawson27 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions